Dermatologists' Perspectives on Biosimilars.

Biosimilars are biologic agents the Food and Drug Administration (FDA) has deemed to have no clinical difference from their reference biologics. In dermatology,  biosimilars are approved for the treatment of psoriasis and hidradenitis suppurativa. Although dermatologists are high prescribers of biologics, they are more reluctant to prescribe biosimilars than other specialists.

Academy of Managed Care Pharmacy.

Highlights of the AMCP Annual Meeting included marketplace trends, the affordability crisis, and the issues facing value-based contracting.

American College of Rheumatology/Association of Rheumatology Health Professionals Annual Meeting.

We present sessions on establishing key clinical trial outcomes in psoriatic arthritis and on delaying the radiographic progression of ankylosing spondylitis.

Challenges and Solutions in Reducing Opioid Misuse and Abuse.

We present some of the approaches to and challenges of the opioid crisis that emerged from thought-leaders at an Academy of Managed Care Pharmacy symposium.

Covering the Cost of the Cure: From Hepatitis C to Cancer, New Therapies Are Straining a System Plagued by Inefficiency.

As researchers devise ever-more-costly therapies and P&T committees try to balance innovation and affordability, managed care experts warn that the struggle to pay the bills could threaten the sustainability of the nation's inefficient health care system.

American Academy of Ophthalmology 2015 Annual Meeting.

The 119th annual meeting of the American Academy of Ophthalmology attracted 28,000 attendees. The authors review key scientific sessions on endophthalmitis, new patient education videos, and ongoing research activities.

American academy of dermatology.

Notable sessions at the American Academy of Dermatology meeting focused on pediatric eczema, infantile hemangiomas, and vaccines. The 2015 Aging in America Conference featured discussions on managing medication use in elderly patients.

Survey reveals trends in eye care: respondents weigh in on adherence, vision screenings, patient support programs, and e-prescribing.

A survey on the eye care market shows areas of agreement and a few sharp differences among ophthalmologists, optometrists, and managed care executives.

Advances in psoriasis treatment: experts comment on recent developments.

Part 1 covers promising biologics that aim to promote safety and efficacy in treating psoriatic lesions. Part 2 addresses the problem of nonadherence to treatment.

Managing MS: Trends, Issues, and Perspectives.

The entry of oral medications for multiple sclerosis into the marketplace and the high cost of biologic drugs are presenting new challenges for stakeholders.

At a glance: dermatology trends in managed care.

According to a 2007 report, most dermatologists predicted that biologic therapies would be used more frequently in the next year; did not follow formularies they considered too restrictive; and expressed concern about denials of paper claims and reimbursements for surgical procedures combined with office visits.